0001237648-20-000071.txt : 20201130
0001237648-20-000071.hdr.sgml : 20201130
20201130155622
ACCESSION NUMBER: 0001237648-20-000071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201127
FILED AS OF DATE: 20201130
DATE AS OF CHANGE: 20201130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aroesty Jason D
CENTRAL INDEX KEY: 0001737532
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22427
FILM NUMBER: 201358139
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HESKA CORP
CENTRAL INDEX KEY: 0001038133
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 770192527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
BUSINESS PHONE: 9704937272
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-27
0
0001038133
HESKA CORP
HSKA
0001737532
Aroesty Jason D
3760 ROCKY MOUNTAIN AVENUE
LOVELAND
CO
80538
0
1
0
0
EVP, International Diagnostics
Common Stock
2020-11-27
4
M
0
11460
106.67
A
11460
D
Common Stock
2020-11-27
4
M
0
1874
106.67
A
13334
D
Common Stock
2020-11-27
4
S
0
10233
126.6812
D
3101
D
Common Stock
2020-11-27
4
S
0
3101
127.439
D
0
D
Incentive Stock Option (right to buy)
106.67
2020-11-27
4
M
0
1874
0
D
2018-07-25
2028-07-24
Common Stock
1874
937
D
Non-Qualified Stock Option (right to buy)
106.67
2020-11-27
4
M
0
11460
0
D
2018-07-25
2028-07-24
Common Stock
11460
5729
D
The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.16 to $127.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected
The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.16 to $127.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected
By: Catherine Grassman For: Jason D. Aroesty
2020-11-30